Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed

NCT01617382 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2024-06-26

No results posted yet for this study

Summary

The purpose of this study is to register the follow-up data of patients who, because of a peritoneal surface malignancy, will undergo cytoreductive surgery and HIPEC.

Conditions

  • Peritoneal Carcinomatosis
  • Pseudomyxoma Peritonei
  • Peritoneal Mesothelioma

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • André JL D'Hoore, PhD · University Clinics Gasthuisberg Department of Abdominal Surgery

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01617382 on ClinicalTrials.gov